• 1. An inter-tangled network of redox-active and conducting polymers as a cathode for ultrafast rechargeable batteries
  Jieun Kim,Han-Saem Park,Tae-Hee Kim,Sung Yeol Kim,Hyun-Kon Song Phys. Chem. Chem. Phys., 2014,16, 5295-5300
• 2. Acetyl group orientation modulates the electronic ground-state asymmetry of the special pair in purple bacterial reaction centers
  P. K. Wawrzyniak,M. T. P. Beerepoot,H. J. M. de Groot,F. Buda Phys. Chem. Chem. Phys., 2011,13, 10270-10279
• 3. An artificial blood vessel implanted three-dimensional microsystem for modeling transvascular migration of tumor cells?
  Xue-Ying Wang,Ying Pei,Min Xie,Zi-He Jin,Ya-Shi Xiao,Yang Wang,Li-Na Zhang,Yan Li,Wei-Hua Huang Lab Chip, 2015,15, 1178-1187
• 4. An artificial CO-releasing metalloprotein built by histidine-selective metallation?
  Inês S. Albuquerque,Hélia F. Jeremias,Miguel Chaves-Ferreira,Dijana Matak-Vinkovic,Omar Boutureira,Carlos C. Rom?o Chem. Commun., 2015,51, 3993-3996
• 5. Acenaphthenic hopanoids, a novel series of aromatised
  Teresita Carrillo-Hernández,Philippe Schaeffer,Pierre Albrecht Chem. Commun., 2001, 1976-1977

Introduction to (R)-3-(2-Chloro-acetylamino)-piperidine-1-carboxylic acid tert-butyl ester (CAS No. 1354010-55-1)

(R-3-(2-Chloro-acetylamino)-piperidine-1-carboxylic acid tert-butyl ester) is a significant compound in the field of pharmaceutical chemistry, widely recognized for its versatile applications in drug development and medicinal research. This compound, identified by its CAS number 1354010-55-1, has garnered considerable attention due to its structural complexity and potential therapeutic benefits.

The molecular structure of (R-3-(2-Chloro-acetylamino)-piperidine-1-carboxylic acid tert-butyl ester) features a piperidine ring substituted with a 2-chloro-acetylamino group and a tert-butyl ester moiety. This unique configuration makes it a valuable intermediate in the synthesis of various pharmacologically active molecules. The presence of the chiral center at the R configuration enhances its specificity and efficacy in biological systems, making it a preferred choice for researchers aiming to develop enantiomerically pure drugs.

In recent years, there has been a growing interest in the development of novel therapeutic agents targeting neurological and infectious diseases. (R-3-(2-Chloro-acetylamino)-piperidine-1-carboxylic acid tert-butyl ester) has been extensively studied for its potential role in these areas. For instance, its structural framework is analogous to several known antiviral and antibacterial compounds, suggesting its utility in designing new drugs with enhanced pharmacokinetic properties.

One of the most compelling aspects of (R-3-(2-Chloro-acetylamino)-piperidine-1-carboxylic acid tert-butyl ester) is its role as a key intermediate in the synthesis of more complex molecules. Researchers have leveraged this compound to develop novel inhibitors targeting specific enzymes involved in disease pathways. For example, studies have demonstrated its effectiveness in inhibiting enzymes associated with inflammation and cancer, highlighting its potential as a lead compound for drug discovery.

The synthesis of (R-3-(2-Chloro-acetylamino)-piperidine-1-carboxylic acid tert-butyl ester) involves multi-step organic reactions, requiring precise control over reaction conditions to ensure high yield and purity. Advanced synthetic methodologies, such as asymmetric hydrogenation and chiral resolution techniques, have been employed to achieve enantiopure forms of this compound. These methods not only enhance the efficiency of the synthesis but also contribute to the overall quality of the final product.

Recent advancements in computational chemistry have further facilitated the study of (R-3-(2-Chloro-acetylamino)-piperidine-1-carboxylic acid tert-butyl ester). Molecular modeling studies have provided insights into its interactions with biological targets, aiding researchers in designing more effective drug candidates. These computational approaches complement traditional experimental methods, offering a holistic view of the compound's pharmacological properties.

The pharmacological profile of (R-3-(2-Chloro-acetylamino)-piperidine-1-carboxylic acid tert-butyl ester) has been thoroughly investigated in various preclinical studies. These studies have revealed its potential as an antagonist for certain neurotransmitter receptors, making it a promising candidate for treating neurological disorders such as Parkinson's disease and epilepsy. Additionally, its ability to modulate immune responses has opened new avenues for developing immunomodulatory therapies.

In conclusion, (R-3-(2-Chloro-acetylamino)-piperidine-1-carboxylic acid tert-butyl ester) represents a significant advancement in pharmaceutical chemistry. Its unique structural features and versatile applications make it an invaluable tool for drug development. As research continues to uncover new therapeutic possibilities, this compound is poised to play a crucial role in the next generation of medicinal innovations.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)